AUTL
Autolus Therapeutics
AUTL
AUTL
43 hedge funds and large institutions have $167M invested in Autolus Therapeutics in 2019 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 16 increasing their positions, 12 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less ownership
Funds ownership: →
33% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 9
51% less capital invested
Capital invested by funds: $344M → $167M (-$177M)
Holders
43
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$8.75M | |
| 2 | +$7.8M | |
| 3 | +$3.73M | |
| 4 |
Victory Capital Management
San Antonio,
Texas
|
+$2.47M |
| 5 |
Capital International Investors
Los Angeles,
California
|
+$2.31M |
Top Sellers
| 1 | -$118M | |
| 2 | -$2.86M | |
| 3 | -$2.73M | |
| 4 |
SGCM
Sand Grove Capital Management
London,
United Kingdom
|
-$1.63M |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$1.15M |